What HeartFlow's latest 10-Q says: 8 signals
HeartFlow filed its latest 10-Q with the SEC on Aug 13, 2026. It discusses cash flow concern, competitor named and compliance burden.
Public (HTFL)Medical Equipment Manufacturing1,001 to 5,000 employeesheartflow.comLinkedIn
- Filed
- Aug 13, 2026
- Filings
- 2
- Signals
- 17
10-Q · latest 10
What HeartFlow's 10-Q filings say
- SEC EDGAR
10-Q
Filed · 8 signals
Heartflow files patent infringement lawsuit against competitor Cleerly, Inc.
The company is engaged in active litigation against competitor Cleerly, alleging infringement on six key patents.
Cleerly, Inc.
Facing DOJ investigation under Anti-Kickback Statute and Civil False Claims Act.
The U.S. Department of Justice is investigating the company's financial arrangements with providers and sales/marketing activities, creating significant legal risk and diverting management attention.
Heartflow to lose 'emerging growth' status, faces new SOX compliance deadline by end of 2026.
The company expects to become a 'large accelerated filer' by year-end 2026, ending its exemption from Sarbanes-Oxley internal control reporting.
$700M
Market value of common stock held by non-affiliates, triggering change in filer status
Losing 'emerging growth company' status, triggering stricter compliance rules after Dec 31, 2026.
The company expects to become a 'large accelerated filer,' losing its JOBS Act exemptions.
$700M
Market value of common stock held by non-affiliates, triggering change in filer status
Recorded a $7.5M asset impairment charge in H1 2026.
The company took a $7.5 million asset impairment charge, indicating a reduction in the carrying value of its assets.
$7.5M
Asset impairment charge for the six months ended June 30, 2026
The company wrote down an asset by $7.5 million in the first half of 2026, a significant financial event indicating a past investment has failed to deliver its expected value.
$7.5M
Asset impairment charge
Burned $38.7M in cash from operations in H1 2026 amid a $43.1M net loss.
The company used $38.7 million in cash for operations in the first six months of 2026, driven by a significant net loss.
$38.7M
Net cash used in operating activities for the six months ended June 30, 2026
- SEC EDGAR
10-Q
Filed · 9 signals
Heartflow files patent infringement lawsuit against competitor Cleerly, Inc.
Heartflow initiated a patent infringement lawsuit against Cleerly, Inc.
Cleerly, Inc.
The U.S. Department of Justice initiated an investigation in October 2025 into the company's financial arrangements with providers and its sales practices.
Faces DOJ investigation into sales practices, forcing potential GTM restructuring.
The company is under a DOJ investigation for potential violations of the Anti-Kickback Statute and Civil False Claims Act related to its sales and marketing activities.
Showing 10 of 17 filing signals. The Signal API returns all of them.
Get them with one API callSignal API · MCP
Track HeartFlow with the Signal API
One POST /v1/companies/enrich call with heartflow.com returns HeartFlow 10-Q signals (sec-10q), each with its source. Or ask Claude through MCP.
2 credits per signal returned; zero-result calls are free. Endpoint reference
curl -X POST https://signals.autobound.ai/v1/companies/enrich \
-H "X-API-KEY: $AUTOBOUND_API_KEY" \
-H "Content-Type: application/json" \
-d '{"domain":"heartflow.com","signal_types":["sec-10q"],"limit":20}'Same industry
10-Q at related companies
Questions about HeartFlow 10-Q
When did HeartFlow file its latest 10-Q?
What did HeartFlow disclose in its latest 10-Q?
Where can I read HeartFlow's 10-Q filing?
Source. Quarterly reports (Form 10-Q) filed with the SEC. Every card links to the filing on EDGAR.
Method. Insights are extracted from the filing text and grouped by category. Numbers are quoted from the filing.
Data as of .